{"id":"W2793234123","doi":"10.1002/mdc3.12613","title":"Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study","year":2018,"lang":"en","type":"article","venue":"Movement Disorders Clinical Practice","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Dystonia Coalition; Allergan; St. Jude Medical; National Institutes of Health; Merz Pharmaceuticals; National Institute of Neurological Disorders and Stroke; University of Cambridge; Glenmark Pharmaceuticals; Ipsen; Jazz Pharmaceuticals; Prothena; Neurocrine Biosciences; Revance; Psyadon Pharmaceuticals; Bristol-Myers Squibb; American Board of Psychiatry and Neurology; Acorda Therapeutics; H. Lundbeck A/S; Sunovion; American Academy of Neurology; F. Hoffmann-La Roche; Civitas Therapeutics; Parkinson's Foundation; Adamas Pharmaceuticals; ACADIA Pharmaceuticals; CHDI Foundation; Medtronic; Sanofi; Pfizer; Parkinson's Disease Foundation; US WorldMeds; Teva Pharmaceutical Industries; Kyowa Kirin Pharmaceutical Development; U.S. Department of Veterans Affairs","keywords":"Cervical dystonia; Medicine; Dystonia; Multicenter study; Anesthesia; Internal medicine; Psychiatry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002066428,0.0003845702,0.0007150199,0.0001809874,0.0001885251,0.00005840706,0.0002550736,0.0004576706,0.0009435329],"category_scores_gemma":[0.004022187,0.0003114328,0.000256119,0.0007906345,0.0003831805,0.0004723385,0.0002187656,0.00153227,0.0005722786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008834371,"about_ca_system_score_gemma":0.0001055321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002262478,"about_ca_topic_score_gemma":0.0003805306,"domain_scores_codex":[0.9949726,0.0009158851,0.00165146,0.001053874,0.0007227907,0.0006834284],"domain_scores_gemma":[0.99692,0.00143633,0.000379347,0.0006944215,0.0002088133,0.0003610767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03109668,0.1665923,0.6809977,0.0001067166,0.0009381734,0.000636405,0.002321387,0.00008243491,0.0006735033,0.0003974253,0.007230088,0.1089271],"study_design_scores_gemma":[0.07845617,0.03177471,0.8153123,0.0001115391,0.0009109657,0.000008525666,0.004885626,0.01631161,0.00005795927,0.002683157,0.04867784,0.0008095747],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9542075,0.0001717206,0.0006979464,0.02178476,0.0008647665,0.002893443,0.000004893855,0.0001839592,0.01919096],"genre_scores_gemma":[0.9726776,0.0004492219,0.001129733,0.02479688,0.0002562849,0.00009357142,0.00002331674,0.00005272904,0.0005206577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1348176,"threshold_uncertainty_score":0.9999697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0432660669349459,"score_gpt":0.4172289391426123,"score_spread":0.3739628722076664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}